Search results :

Budesonide

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: A07EA06, D07AC09, R01AD05, R03BA02

Side effects

Options: Show MedDRA Preferred Terms,   display all 30 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Cushing's syndrome 31% - 47.6% 24.2% x x x x x
Respiratory tract infection 5.68% - 38% 6.54% - 36% x x x x x x x x x
Headache postmarketing, 11.4% - 28% 10.5% - 21.2% x x x x x x x x x x x x x x x
Acne 0.787% - 22.8% 0% - 13.1% x x x
Sweating increased 5.22% - 17.9% 3.03% x x x
Otitis media 1.3% - 12% 0.9% - 11% x x x x x
Rhinitis 7% - 12% 9% x x x x x x x
Nausea 1.8% - 13.1% 0.9% - 9.35% x x x x x x x x x x x
Cushingoid 1.18% - 36.6% 0% - 4.92% x x x x
Nasopharyngitis 9.3% 8.3% x
Contusion postmarketing, 4.55% - 14.8% 3.5% - 11.2% x x x x x x
Ankle edema 2.07% - 8.97% 2.1% - 5.61% x x
Dizziness 4.67% - 12.4% 4.67% - 6.06% x x x x x
Back pain 5.68% - 11.7% 9.09% - 9.35% x x x x x
Insomnia 2.35% - 11% 3.1% - 6.56% x x x x x x x
Dyspepsia 3.41% - 11.7% 3.03% - 3.74% x x x x x x
Flatulence 2.35% - 8.28% 1.94% - 6.06% x x x x
Arthralgia 1.96% - 5% 1.55% - 6.06% x x x x x
Cough postmarketing, 2% - 9% 1% - 5% x x x x x x x x x x x x x
Gastroenteritis 5% 4% x x x x x x
Fatigue 0% - 8.21% 1.94% - 7.58% x x x x x x x x x x x x x
Candida infection 3% - 4% 2% x x x x x x x
Diarrhoea 2% - 10% 2% x x x x x x x
Cramp muscle 4% x x x x
Viral infection 3% - 6% 3% x x x x x
Vomiting 2% - 7.09% 3% - 7.58% x x x x x x x x x
Ear infection 2% - 5% 4% x x x x x x
Abdominal pain upper 3.15% - 3.92% 1.94% x
Hirsutism 0% - 5.15% 0% - 1.87% x x x
Pain postmarketing, 2.27% - 11.7% 7.48% - 9.09% x x x x x x x x x
Blood cortisol decreased 2.36% - 4.31% 0.388% x
Abdominal pain 2% - 16.8% 2% - 16.8% x x x x x x x x x
Epistaxis 2% - 8% 1% - 5% x x x x x x x x x x
Hoarseness 2-4% x x
Vision blurred 3% x x
Nasal congestion 2.7% 0.4% x
Viral upper respiratory tract infection 2.2% 1.3% x
Rhinitis allergic 2.2% 1.3% x
Conjunctivitis 1% - 4% 2% x x x x
Rash postmarketing, 1% - 4.1% 3% - 6.06% x x x x x x x x x x x x x x x
Menstrual disorder 2% x x x x
Nasal irritation 2% 1% x x x x x
Abdominal distension 1.57% - 2.35% 0.775% x
Viral diarrhoea 1.8% 0.4% x
Buffalo hump 0.69% - 3.45% 0% - 1.87% x x
Pharyngitis postmarketing, 2.7% - 4% 1.7% - 3% x x x x x x x x x
Oral candidiasis 1.3% 0.4% x x x
Fluid retention 0.784% - 1.61% 1.16% - 1.64% x
Constipation 0.394% - 1.96% 0.775% x
Urinary tract infection 0.394% - 1.96% 0.388% x x
Flushing 0% - 1.61% 1.16% - 1.64% x x x
Hyperadrenocorticism postmarketing x x x x x x x x x x x x x
Anaphylactic shock postmarketing x x x x x x x x x x
Angioedema postmarketing x x x x x x x x x x x x x x
Anosmia postmarketing x x x x
Anxiety postmarketing x x x x x x
Mental disorder postmarketing x x x x x
Bronchospasm postmarketing, 2% 1% x x x x x x x x x x
Bronchitis postmarketing x x x x x x
Infection postmarketing x x x x x x x x
Connective tissue disorder postmarketing x x x x x x
Dermatitis postmarketing x x x x x x x x x
Dermatitis contact postmarketing x x x x x x
Endocrine disorder postmarketing x x x
Eye disorder postmarketing x x x x x x x
Body temperature increased postmarketing x x x x x x x
Glaucoma postmarketing x x x x x x x x
Cardiac disorder postmarketing x x x
Hypersensitivity postmarketing x x x x x x x x
Type IV hypersensitivity reaction postmarketing x x x x x x x x x x x x
Immune system disorder postmarketing x x x x x x x x
Irritability postmarketing x x x x x x
Mediastinal disorder postmarketing x x x x x x
Necrosis ischaemic postmarketing x x x x
Nervous system disorder postmarketing x x x x
Nervousness postmarketing x x x x x x x x x
Osteoporosis postmarketing x x x x x
Palpitations postmarketing, 2% - 8.28% x x x x x x x x
Pharyngeal disorder postmarketing x x x x x
Pruritus postmarketing x x x x x x x x x
Benign intracranial hypertension postmarketing x x x
Psychotic disorder postmarketing x x x x x x
Sinusitis postmarketing, 8% x x x x x x x x
Swelling postmarketing x x x x
Urticaria postmarketing, 6% x x x x x x x x x x x x x x
Wheezing postmarketing x x x
Agitation postmarketing x x x x x x x
Mood swings postmarketing, 3.53% - 6.45% 3.28% - 4.26% x x x x x x x x
Cataract postmarketing x x x x x x x x
Growth retardation postmarketing x x x x x x x x
Skin irritation postmarketing x x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x
Psychiatric symptom postmarketing x x x x x x x x
Intraocular pressure increased postmarketing x x x x x
Nasal septum perforation postmarketing x x x x x x
Throat sore postmarketing x x x x x x x
Burning in throat postmarketing x x x x
Throat irritation postmarketing x x x x x x x x x
Dysphonia postmarketing x x x x
Abscess x
Adrenal insufficiency x x x
Alopecia x x
Amnesia x
Anaemia x x
Anorexia x x x x
Anus disorder x x
Arthritis x
Asthenia x x x x
Clotting x x x
Coagulopathy x x x x
Bone disorder x x
Breast disorder x
Neck pain x x
Chest pain x x x x x x
Allergic granulomatous angiitis x x x
Confusional state x x
Dysgeusia x x
Dyspnoea x x x
Dysuria x x
Ear pain x x x x x x
Ecchymosis x x
Eczema x x x x x x x
Enteritis x x
Congenital eye disorder x x
Eye infection x x x x
Fracture x x x x x x
Gastrointestinal disorder x
Glossitis x x
Haematuria x x
Haemorrhage x x x x x
Haemorrhoids x x
Herpes simplex x x x x
Hypertension x x
Hypokalaemia x x x x
Influenza x x
Intestinal obstruction x x
Leukocytosis x x
Metrorrhagia x x
Hypertonia x x
Nocturia x x
Paraesthesia x x
Purpura x x x x x
Pyuria x x
Skin disorder x x
Sneezing x x
Gastric disorder x x
Stridor x x x
Syncope x x
Tachycardia x x
Thirst x x
Tooth disorder x x
Tremor x x x x x x
Ulcer x x
Pollakiuria x x
Urinary tract disorder x
Angiopathy x
Vertigo x x
Disorder sight x x x x
Weight increased x x x x x
Dry mouth x x x x x
Bronchoconstriction x x
Rash pustular x x x x
Withdrawal symptom x
Migraine x x
Tongue oedema x x
Red blood cell sedimentation rate increased x x
Impaired healing x x
Phosphatase alkaline increased x x
Skin striae 0% - 2.27% 0% - 1.87% x x x
Malnutrition x x x x
Scab x x x
Lightheadedness x
Malaise x x
Myalgia x x x x x x x x
Hair growth increased x
Increased appetite x x
Epigastric pain x x
Tenderness x
Ache x x
Gravitational oedema x x
Lymphadenopathy cervical x x x x
Arthritis aggravated x
Bronchospasm paradoxical x
Secondary adrenocortical insufficiency x x x x x x x x x
Candida albicans infection x x x x
Gastrointestinal fistula x x
Hyperkinesia x x x x x x
Bad taste x x x x
Face oedema x x
Sexual dysfunction x
Cough increased x x
C-reactive protein increased x x
Ear pruritus x x
Infestation NOS x x x
Blood and lymphatic system disorders x x x
Ear and labyrinth disorders x x x
Allergic conditions x
Sleep disorder x x
Crohns disease aggravated x x
Local reaction x x
Oropharyngeal candidiasis x
Procedural complication x x
Appetite absent x x
Somnolence x x
Abnormal vision x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

BUDESONIDE / ENTOCORT CAPSULE 3MG

Side effects:12
Source:Health Canada

BUDESONIDE / RHINOCORT

Side effects:12
Source:FDA

BUDESONIDE / RHINOCORT

Side effects:17
Source:FDA

BUDESONIDE / RHINOCORT TURBUHALER 100 MCG/DOSE

Side effects:19
Source:Health Canada

BUDESONIDE / PULMICORT NEBUAMP 0.125 MG/ML

Side effects:20
Source:Health Canada

BUDESONIDE

Side effects:25
Source:FDA Structured Product Label

Budesonide controlled ileal release capsules / ENTOCORT

Side effects:28
Source:medicines.org.au

budesonide for oral inhalation / PULMICORT

Side effects:30
Source:medicines.org.au

budesonide for nasal inhalation / RHINOCORT HAYFEVER

Side effects:31
Source:medicines.org.au

BUDESONIDE

Side effects:36
Source:FDA Structured Product Label

BUDESONIDE

Side effects:36
Source:FDA Structured Product Label

Budesonide

Side effects:45
Source:FDA Structured Product Label

BUDESONIDE / PULMICORT RESPULES

Side effects:56
Source:FDA

BUDESONIDE

Side effects:67
Source:FDA Structured Product Label

BUDESONIDE

Side effects:79
Source:FDA Structured Product Label

BUDESONIDE

Side effects:80
Source:FDA Structured Product Label

BUDESONIDE / ENTOCORT EC

Side effects:80
Source:FDA

BUDESONIDE

Side effects:108
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label